Demcizumab (Anti-DLL4)Demcizumab (Anti-DLL4)
Move your mouse over image or click to enlarge

Demcizumab (Anti-DLL4)

Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.
Cat# Size Price Qty Buy
A2520-1mg*25 1mg*25
£3,415.00
A2520-1mg*5 1mg*5
£1,138.00
A2520-1mg 1mg
£384.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2520

Related Documents